David S. Wilson
Director
David has held a variety of senior international commercial roles in healthcare companies including Boehringer Mannheim Diagnostics (now Roche Diagnostics) and Genzyme Corporation. As Director of Business Development for Genzyme’s Diagnostics Products division, David was responsible for the identification, screening and commercial evaluation of new products, platform technologies and businesses for acquisition across all global markets outside the Americas. Previously David led the division’s international sales and marketing teams with responsibility for the growth and development of sales and distribution channels throughout Europe.
David has been an Advisor with the publically funded Innovation Advisory Service, and a non-executive director and founding member of the South East Health Technologies Alliance. He has an MBA from the Open University Business School, a BSc (Hons) in Biochemistry with Microbiology from the University of St Andrews and the University of California, and he has published research carried out at the Imperial Cancer Research Fund (now Cancer Research UK).